The mechanistic study revealed that M2 microglial EVs attenuated BBB disruption in the acute stage of cerebral ischemia by delivering miR-23a-5p, which targeted TNF and regulated MMP3 and NFκB p65 expression. This evidence concerns the gene NFKB1 and Cerebral ischemia.